Black Diamond Therapeutics Inc (BDTX)
2.74
-0.11
(-3.86%)
USD |
NASDAQ |
Nov 15, 11:35
Black Diamond Therapeutics Cash and Short Term Investments (Quarterly): 112.68M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 112.68M |
| June 30, 2024 | 122.97M |
| March 31, 2024 | 115.20M |
| December 31, 2023 | 131.40M |
| September 30, 2023 | 144.26M |
| June 30, 2023 | 89.53M |
| March 31, 2023 | 103.37M |
| December 31, 2022 | 122.81M |
| September 30, 2022 | 144.18M |
| June 30, 2022 | 160.89M |
| March 31, 2022 | 179.74M |
| Date | Value |
|---|---|
| December 31, 2021 | 209.79M |
| September 30, 2021 | 235.01M |
| June 30, 2021 | 263.47M |
| March 31, 2021 | 290.06M |
| December 31, 2020 | 315.07M |
| September 30, 2020 | 333.07M |
| June 30, 2020 | 204.49M |
| March 31, 2020 | 357.19M |
| December 31, 2019 | 154.67M |
| September 30, 2019 | 78.66M |
| December 31, 2018 | 51.66M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
89.53M
Minimum
Jun 2023
357.19M
Maximum
Mar 2020
189.49M
Average
157.78M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 9.796B |
| Vanda Pharmaceuticals Inc | 376.26M |
| Ligand Pharmaceuticals Inc | 219.64M |
| Agios Pharmaceuticals Inc | 1.005B |
| ADMA Biologics Inc | 86.71M |